About Aquyre
Aquyre is a Healthcare company based in Weston (United States) founded in 2007 by Bertrand Le Conte de Poly. Cellular-level optical biopsy imaging systems are developed for tissue analysis. Aquyre has raised $28.59 million across 4 funding rounds from investors including Ceros and Alchemist Accelerator. Aquyre offers products and services including Dynamic Cell Imaging (DCI) and Van Gogh. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is CellTivity Scientific, Inc. Its competitors include Pictor Labs, BioImagene and Omnyx; 2 of its 3 listed competitors have raised funding.
Company details
Aquyre was founded in 2007 and is based in Weston, United States. Cellular-level optical biopsy imaging systems are developed within the medical imaging sector. The CelTivity system is offered to enable non-invasive, nondestructive imaging at cellular resolution. Light-based techniques are utilized to perform optical biopsies beneath tissue surfaces, supporting research applications in tissue analysis.
- Headquarters Weston, United States
- Founders Bertrand Le Conte de Poly
- SectorsHealthcare
- Phone•••• ••••
- Website aquyre.com
- Social LinkedIn X
- Legal Name Celltivity Scientific, Inc.
- Total Equity Funding$28.59M (USD)
in 4 rounds
- Latest Funding Round$3.22M (USD), Series A
Oct 2023
- InvestorsCeros
& 1 more
Products & Services of Aquyre
Aquyre offers a comprehensive portfolio of products and services, including Dynamic Cell Imaging (DCI) and Van Gogh.
Captures metabolic activity in biopsies for rapid cancer detection.
Generates heat maps of cellular activity to assess biopsy samples.
Funding Insights of Aquyre
Aquyre has successfully raised a total of $28.59M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3.22 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.59M
- Total Rounds 4
- Last Round Series A — $3.22M
- Investors Count 2
All 4 funding rounds of Aquyre with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $3.22M | Series A | – | – | – |
| May 2022 | $5.42M | Series A | – | – | – |
| Oct 2021 | $19.95M | Series A | – | – | |
| Oct 2021 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Aquyre
Aquyre has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Ceros and Alchemist Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Enterprise startups are accelerated via a 6-month program. | alchemistaccelerator.com | San Francisco, United States | ||
Ceros is recognized as a full-service brokerage platform for advisors. | 1994 | cerosfs.com | Rockville, United States |
Investor details for Aquyre
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aquyre
10 people are tracked at Aquyre (4 in leadership, 3 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Bertrand Le Conte de Poly | Founder, Chief Strategy & Technology Officer | Leadership |
Samuel Eberts III | Chairman & CEO | Leadership |
Heidi Geist | Vice President, People Operations | Leadership |
Nicholas Mancini | Area VP | Leadership |
Thierry Thaure | Director | Board & advisors |
Ronald Sorenson | Director | Board & advisors |
Cosme Ordonez | Director | Board & advisors |
François Grammont | SVP, Manufacturing | Team |
Greg Bowles | SVP, Sales & Marketing | Team |
Dennis Sheahan | Senior Clinical Sales Representative | Team |
Complete people profiles for Aquyre
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aquyre
3 dated milestones of Aquyre across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Aquyre is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $3.2M.
Competitors of Aquyre
Aquyre has 3 listed competitors in our database, 2 of them funded. They include Pictor Labs, BioImagene and Omnyx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | AI-based tools for pathological image analysis are provided to labs. | ||
| bioimagene.com | 2003 | Sunnyvale, United States | $40.2M | 40 | Digital pathology tools are developed for diagnostics and drug discovery. | |
| omnyx.com | 2008 | Pittsburgh, United States | Digital pathology solutions are offered for oncology applications. |
Detailed competitors of Aquyre
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Aquyre (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aquyre
Complete news archive for Aquyre
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aquyre
Aquyre was founded in 2007 and raised its 1st funding round 14 years after it was founded.
Aquyre is headquartered in Weston, United States. It is registered at Weston, Florida, United States.
Aquyre is a funded company, having raised a total of $28.59M across 4 funding rounds to date.
Aquyre was founded in 2007 and is based in Weston, United States. Cellular-level optical biopsy imaging systems are developed within the medical imaging sector. The CelTivity system is offered to enable non-invasive, nondestructive imaging at cellular resolution. Light-based techniques are utilized to perform optical biopsies beneath tissue surfaces, supporting research applications in tissue analysis.
Aquyre's top competitors include Pictor Labs, BioImagene and Omnyx.
Aquyre offers Dynamic Cell Imaging (DCI) and Van Gogh.
Aquyre has 2 investors. Key investors include Ceros, and Alchemist Accelerator.
Aquyre operates through Celltivity Scientific, Inc..